ING Groep NV vs Twist Bioscience Corp — how do they compare? ING Groep NV trades at $35.49 (market cap $101.22B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: ING Groep NV is far larger — about 13.1× Twist Bioscience Corp's market cap, and ING Groep NV pays a 3.73% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| ING | TWST | |
|---|---|---|
Market Cap | $101.22B | $7.72B |
Sector | Financials | Health |
52-Week High | $35.92 | $124.88 |
52-Week Low | $23.66 | $24.16 |
Dividend Yield | 3.73% | — |
Enterprise Value | — | $7.65B |
Trailing returns across standard periods
The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.
Read more on ING →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →